3-1Nternexin, a Protein Ubiquitous Intermediate Filament-Associated

Total Page:16

File Type:pdf, Size:1020Kb

3-1Nternexin, a Protein Ubiquitous Intermediate Filament-Associated /3-1nternexin, a Ubiquitous Intermediate Filament-associated Protein EUGENE W. NAPOLITANO, JOEL S. PACHTER, STEVENS. M. CHIN, and RONALD K. H. LIEM Department of Pharmacology, New York University School of Medicine, New York, New York 10016 ABSTRACT In this article we show a Triton-insoluble, intermediate filament-associated protein of ~70 kD to be expressed ubiquitously in diverse mammalian cell types. This protein, assigned the name/3-internexin, exhibits extreme homology in each of the various cell lines as demonstrated by identical limited peptide maps, similar mobilities on two-dimensional gels, and detection in Triton-soluble and -insoluble extracts. ~-Internexin also shares some degree of homology with a-internexin, an intermediate filament-associated protein isolated and purified from rat spinal cord, which accounts for the immunologic cross-reactivity displayed by these polypeptides. Light microscopic immunolocalization of ~-internexin with a monoclo- nal antibody (mAb-IN30) reveals it to be closely associated with the vimentin network in fibroblasts. The antigen is also observed to collapse with the vimentin reticulum during the formation of a juxtanuclear cap induced by colchicine treatment. Ultrastructural localization, using colloidal gold, substantiates the affinity of ~-internexin for cytoplasmic filaments and, in addition, demonstrates its apparent exclusion from the intranuclear filament network. We examine also the resemblance of ~-internexin to a microtubule-associated polypeptide and the constitutively synthesized mammalian heat shock protein (HSP 68/70). Cytoskeletal-associated proteins are defined by their ability to cated in mediating the interactions between microtubules and co-isolate and interact in situ with one of the filamentous neurofilaments (1, 18). Immunoelectron microscopy studies networks indigenous to most eukaryotic cell types. These have shown that the peripherally located 200-kD neurofila- polypeptides are thought to subserve a number of putative ment-associated subunit appears to serve as an interfilamen- functions with regard to cytoskeletal organization and regu- tous cross-linker in myelinated axons (11, 12, 19). lation. They may effect dynamic changes of cytoskeletal ar- In this report we describe an intermediate filament (IF)- chitecture in vivo by altering the polymerization state of associated protein designated ~-internexin which is present in cytoskeletal subunit components; engendering a redistribu- many diverse eukaryotic cell types. We examine the relation- tion of intracellular filaments; serving as potential cross- ship of this polypeptide to a-internexin, an IF-associated bridging agents between subcellular organelles (e.g., between protein originally isolated from rat spinal cord and optic neurofilaments and microtubules); or harboring specific cat- nerve, which was found to bind to several IF subunit proteins alytic activities (e.g., phosphokinase). Support for some of (22). The presence of B-internexin in all cell types investigated, these hypothetical roles is derived from studies conducted in and the homology of this protein isolated from the different a number of laboratories. Numerous investigators have ob- cells were established by two-dimensional gel electrophoresis, served that high molecular weight microtubule-associated pro- peptide mapping, and antibody localization. Its solubility teins (MAPs) ~ as well as lower molecular weight tau-proteins properties and uitrastructural localization render this protein promote the in vitro assembly of tubulin subunits into poly- a likely candidate for the class of IF-associated proteins that meric microtubules (4, 26, 32). MAPs have also been impli- may play an integral role in the regulation of the IF-reticulum. In this paper we will also discuss the possible relatedness of ~Abbreviations used in this paper." HSP, heat shock protein; IF, B-internexin to a protein that co-isolates with microtubules intermediate filament; MAP, microtubule-associated protein; SV8, and to the most commonly elicited, constitutively synthesized Staphylococcus aureus V8. mammalian heat shock protein of ~70 kD (HSP 68/70). THE IOURNAL OF CELL BIOLOGY • VOLUME 101 OCTOBER 1985 1323 1331 1323 © The Rockefeller University Press . 0021-9525/85/10/1323/09.$1.00 MATERIALS AND METHODS achieved by sequential addition of components used in the chloramine T method (10). After 20 ul phosphate buffer (0.5 M, pH 7.5) was pipetted into each tube, 20 ~1 Na125I, resuspended in phosphate buffer (0.5 uCi/20 ul), was Cell Culture and Cytoskeletal Extracts: Five culture lines were added. 20 #1 chloramine T ( 1 mg/ml) was applied to each tube, and after the used to isolate IF-rich fractions and subsequently detect the IF-associated absorption of liquid was allowed to proceed for 30 min, 0.5 ml sodium protein dubbed fl-internexin: human glioma cells (U25 I-MG), Chinese hamster metabisulfite (2 mg/ml) was added to terminate the reaction. 0.5 ml NaI (2 o~ary fibroblasts (CHO), rat kangaroo kidney epithelial cells (PIK2), human mg/ml) was placed into each sample tube, and the gel slices were then rinsed foreskin fibroblasts (FS-4), and neuroblastoma-glioma hybrids (NGI08-15). with several changes of 10% methanol. Radiolabeled proteins in these slices All cultures were grown on 100-mm sterile Falcon tissue culture dishes (Falcon were used in peptide mapping studies by the method described above. Labware, Oxnard, CA) in Dulbecc&s modified Eagle's medium supplemented Antiserum Production: Polyclonal antisera directed against gel-pu- with 10% fetal calf serum except the neuroblastoma-glioma hybrid line, which rified a-internexin (22) derived from rat spinal cord were raised in rabbit and was maintained in Dulbecco's modified Eagle's medium with 10% fetal calf guinea pig by use of the following protocol: (a) A subcutaneous injection of serum containing 0.1 mM hypoxanthine, l ~M aminopterin, and 16 ~M 25-50 #g protein, emulsified in Freund's complete adjuvant, was injected thymidine. subcutaneously followed by immediately by two intradermal injections into Cytoskeletal extracts from monolayer cultures were prepared by Dounce the hind paws. (b) 2 wk later, a second inoculation of protein, emulsified in homogenization of freshly harvested cells in an ice-cold (4"C) buffer consisting Freund's incomplete adjuvant, was administered as before. (c) Step b was of l0 mM phosphate (pH 6.8), 0.1 M NaCl, l mM EDTA containing 1% repeated for three more 2-wk intervals. (d) The animals were bled intermittently Triton X-100, 0.5 mg/ml DNase I (Worthington Biochemical Corp., Freehold, during these periods, and the immune sera were tested for specificity by N J), l0 mM MgCl2, 2 mM phenylmethylsulfonyl fluoride, and l uM Aprotinin immunoblotting and immunofluorescence assays described below. (Sigma Chemical Co., St. Louis, MO) followed by sedimentation in an Eppen- Mouse monoclonal antibodies and ascites directed against a-internexin were dorf centrifuge at 12,000 g for 10 min at 4*(?. Triton-insoluble pellets were produced as described by Wang et al. (30) employing the procedure of Kohler solubilized in SDS sample buffer (16), diluted in lysis buffer (21), and subjected and Milstein (15) as modified by Dippold et al. (6). The schedule of immuni- to two-dimensional gel electrophoresis and fluorography as described below. zation of female BALB/c mice was similar to that of the guinea pig. Approxi- Labeling of Cell Cultures: Cultures grown in 100-mm Falcon dishes mately 50-100 ug of purified antigen, emulsified in complete Freund's adjuvant, were labeled with [sSS]methionine by washing cells three times with phosphate- was used for the initial immunization. In four subsequent inoculations, purified buffered saline (PBS) and preincubating the cultures with 3 ml methionine-free antigen was mixed with Freund's incomplete adjuvant and injected subcuta- medium (Select-Amine Kit, Gibeo Laboratories Inc., Grand Island, NY) for 1 neously at 2-wk intervals. The last injection of antigen (without adjuvant) was h at 37"C. 100 ~Ci/ml of [sSS]methionine (>1,000 Ci/mmol, New England administered intravenously 3 d before the fusion. Clonal supernatants were Nuclear. Boston, MA) was then added for another hour at 37"C. Cytoskeletal then screened for anti-a-internexin activity using the microspot assay described extracts were then prepared as described above. elsewhere (19). Isolation of MAPs: MAPs were isolated from rat spinal cord by the Affinity Chromatography: Purification of the antisera by affinity method of Vallee (28). The spinal cords were homogenized in ice-cold reassem- chromatography was executed essentially as described in the pamphlet Affinity bly buffer of 0. l M 2-(N-morpholino)ethane sulfonie acid, 0.5 mM MgCl2, and Chromatography, Principles and Methods (Pharmacia, Uppsala, Sweden). In l mM EGTA, pH 6.8, with a Dounce homogenizer, and centrifuged at 40,000 brief, CNBr-activated Sepharose 4B (Sigma Chemical Co.) was swollen for 15 rpm in a Beckman Ti 75 rotor (Beckman Instruments Inc., Palo Alto, CA) for min in l mM HCI and then washed with coupling buffer (0. l M NaHCO3, pH 30 min in the cold. Microtubule proteins were obtained through one cycle of 8.3, 0.5 M NaCl). The gel suspension was immediately transferred (for covalent assembly and disassembly (25, 26). The resulting superuatant containing the coupling) to a solution of purified antigen (~ l mg/ml), dissolved in coupling disassembled microtubules was then removed, and taxol (from the National buffer containing 0.1% SDS, and mixed in an end-over-end rotator overnight Cancer Institute) was added to a final concentration of 20 ~M in the presence at 4°C. Active groups remaining on the gel were then blocked by incubation of I mM GTP. The solution was incubated for 30 min at 37"C and centrifuged with 0.2 M glycine, pH 8.0, overnight at 4"C. Nonspecifically adsorbed protein at 40,000 rpm in a Beckman Ti 75 rotor at room temperature for 30 min. The was eluted from the gel suspension by 0. l M acetate buffer, pH 4, containing MAPs were removed from the resulting pellet by washing the pellet with 0.3 M 0.5 M NaCl and then rinsed extensively with coupling buffer.
Recommended publications
  • Blood Neurofilament Light Chain: the Neurologist's Troponin?
    biomedicines Review Blood Neurofilament Light Chain: The Neurologist’s Troponin? Simon Thebault 1,*, Ronald A. Booth 2 and Mark S. Freedman 1,* 1 Department of Medicine and the Ottawa Hospital Research Institute, The University of Ottawa, Ottawa, ON K1H8L6, Canada 2 Department of Pathology and Laboratory Medicine, Eastern Ontario Regional Laboratory Association and Ottawa Hospital Research Institute, University of Ottawa & The Ottawa Hospital, Ottawa, ON K1H8L6, Canada; [email protected] * Correspondence: [email protected] (S.T.); [email protected] (M.S.F.) Received: 4 November 2020; Accepted: 18 November 2020; Published: 21 November 2020 Abstract: Blood neurofilament light chain (NfL) is a marker of neuro-axonal injury showing promising associations with outcomes of interest in several neurological conditions. Although initially discovered and investigated in the cerebrospinal fluid (CSF), the recent development of ultrasensitive digital immunoassay technologies has enabled reliable detection in serum/plasma, obviating the need for invasive lumbar punctures for longitudinal assessment. The most evidence for utility relates to multiple sclerosis (MS) where it serves as an objective measure of both the inflammatory and degenerative pathologies that characterise this disease. In this review, we summarise the physiology and pathophysiology of neurofilaments before focusing on the technological advancements that have enabled reliable quantification of NfL in blood. As the test case for clinical translation, we then highlight important recent developments linking blood NfL levels to outcomes in MS and the next steps to be overcome before this test is adopted on a routine clinical basis. Keywords: neurofilament light chain; biomarkers; multiple sclerosis 1. Neurofilament Structure and Function Neurofilaments are neuronal-specific heteropolymers conventionally considered to consist of a triplet of light (NfL), medium (NfM) and heavy (NfH) chains according to their molecular mass [1].
    [Show full text]
  • Immunological Properties and Cdna Sequence Analysis of an Intermediate-filament-Like Protein from Squid Neuronal Tissue
    Journal of Cell Science 106, 1283-1290 (1993) 1283 Printed in Great Britain © The Company of Biologists Limited 1993 Immunological properties and cDNA sequence analysis of an intermediate-filament-like protein from squid neuronal tissue James Adjaye*, Philip J. Marsh and Peter A. M. Eagles† Department of Molecular Biology and Biophysics, The Randall Institute, King’s College London, 26-29 Drury Lane, London WC2B 5RL, UK *Present address: Max-Planck-Institute for Biophysical Chemistry, Department of Biochemistry, PO Box 2841, D-3400, Goettingen, FRG †Author for correspondence SUMMARY A cDNA library has been constructed in the expression (IF) proteins. The rod has the classical heptad repeats vector gt11 from mRNA isolated from squid (Loligo indicating coiled-coil-forming ability, and the predicted forbesi) optic lobes. The library was screened with anti- lengths of the coils are similar to coils 1a, 1b and 2 of bodies generated against purified squid neurofilaments. intermediate filaments. At the C-terminal end of the rod A positive clone was isolated, which harboured a gt11 there is a strongly conserved IF epitope, and a fusion recombinant having an insert size of 3.5 kb. Hybridiz- protein containing SNLK is recognised by the pan- ation analysis by Southern and northern blotting specific intermediate filament antibody, IFA. A poly- showed that the corresponding protein is encoded by a clonal antibody raised against SNLK has been used to single gene that gives rise to a transcript of 2.6 kb. show that the protein is present only in neuronal tissues Translation of the full nucleotide sequence of the gene and that it is immunologically related to neurofilaments revealed an open reading frame covering 557 amino from Myxicola but not from mammals.
    [Show full text]
  • Neurofilaments: Neurobiological Foundations for Biomarker Applications
    Neurofilaments: neurobiological foundations for biomarker applications Arie R. Gafson1, Nicolas R. Barthelmy2*, Pascale Bomont3*, Roxana O. Carare4*, Heather D. Durham5*, Jean-Pierre Julien6,7*, Jens Kuhle8*, David Leppert8*, Ralph A. Nixon9,10,11,12*, Roy Weller4*, Henrik Zetterberg13,14,15,16*, Paul M. Matthews1,17 1 Department of Brain Sciences, Imperial College, London, UK 2 Department of Neurology, Washington University School of Medicine, St Louis, MO, USA 3 a ATIP-Avenir team, INM, INSERM , Montpellier university , Montpellier , France. 4 Clinical Neurosciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom 5 Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada 6 Department of Psychiatry and Neuroscience, Laval University, Quebec, Canada. 7 CERVO Brain Research Center, 2601 Chemin de la Canardière, Québec, QC, G1J 2G3, Canada 8 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland. 9 Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY, 10962, USA. 10Departments of Psychiatry, New York University School of Medicine, New York, NY, 10016, 11 Neuroscience Institute, New York University School of Medicine, New York, NY, 10016, USA. 12Department of Cell Biology, New York University School of Medicine, New York, NY, 10016, USA 13 University College London Queen Square Institute of Neurology, London, UK 14 UK Dementia Research Institute at University College London 15 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden 16 Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden 17 UK Dementia Research Institute at Imperial College, London * Co-authors ordered alphabetically Address for correspondence: Prof.
    [Show full text]
  • Intermediate Filament Accumulation Can Stabilize Microtubules in Caenorhabditis Elegans Motor Neurons
    Intermediate filament accumulation can stabilize microtubules in Caenorhabditis elegans motor neurons Naina Kurupa, Yunbo Lia, Alexandr Goncharova, and Yishi Jina,b,1 aNeurobiology Section, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093; and bDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093 Edited by H. Robert Horvitz, Massachusetts Institute of Technology, Cambridge, MA, and approved February 11, 2018 (received for review December 21, 2017) Neural circuits utilize a coordinated cellular machinery to form and Results eliminate synaptic connections, with the neuronal cytoskeleton Identification of IF Genes That Regulate Synapse Rewiring. At the playing a prominent role. During larval development of Caenorhabditis end of larval stage 1 (L1), the dorsal D (DD)-type motor neurons elegans, synapses of motor neurons are stereotypically rewired rewire their presynaptic connections from the ventral nerve cord through a process facilitated by dynamic microtubules (MTs). Through a (VNC) to the dorsal nerve cord (DNC), concurrent with the genetic suppressor screen on mutant animals that fail to rewire synap- birth of ventral D (VD)-type motor neurons, which then form ses, and in combination with live imaging and ultrastructural studies, synapses along the VNC (19). We visualized DD-neuron pre- we find that intermediate filaments (IFs) stabilize MTs to prevent syn- synaptic terminals using a GFP-tagged synaptobrevin (SNB- apse rewiring. Genetic ablation of IFs or pharmacological disruption of 1::GFP) reporter (juIs137:Pflp-13 SNB-1::GFP). In L1 animals, IF networks restores MT growth and rescues synapse rewiring defects discrete synaptic puncta were present along the ventral neurites in the mutant animals, indicating that IF accumulation directly alters MT (18), but in late larvae and adults, synaptic puncta were only seen stability.
    [Show full text]
  • Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments
    The Journal of Neuroscience, August 15, 2001, 21(16):6026–6035 Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments Takeshi Ishihara, Makoto Higuchi, Bin Zhang, Yasumasa Yoshiyama, Ming Hong, John Q. Trojanowski, and Virginia M.-Y. Lee Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 Previous studies have shown that transgenic (Tg) mice overex- particular NFL, resulted in a dramatic decrease in the total pressing human tau protein develop filamentous tau aggre- number of tau-positive spheroids in spinal cord and brainstem. gates in the CNS. The most abundant tau aggregates are found Concomitant with the reduction in spheroid number, the bigenic in spinal cord and brainstem in which they colocalize with mice showed delayed accumulation of insoluble tau protein in neurofilaments (NFs) as spheroids in axons. To elucidate the the CNS, increased viability, reduced weight loss, and improved role of NF subunit proteins in tau aggregate formation and to behavioral phenotype when compared with the single T44 Tg test the hypothesis that NFs are pathological chaperones in the mice. These results imply that NFs are pathological chaperones formation of intraneuronal tau inclusions, we crossbred previ- in the development of tau spheroids and suggest a role for NFs ously described tau (T44) Tg mice overexpressing the smallest in the pathogenesis of neurofibrillary tau lesions in neurodegen-
    [Show full text]
  • Neurofilaments and Neurofilament Proteins in Health and Disease
    Downloaded from http://cshperspectives.cshlp.org/ on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Neurofilaments and Neurofilament Proteins in Health and Disease Aidong Yuan,1,2 Mala V. Rao,1,2 Veeranna,1,2 and Ralph A. Nixon1,2,3 1Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York 10962 2Department of Psychiatry, New York University School of Medicine, New York, New York 10016 3Cell Biology, New York University School of Medicine, New York, New York 10016 Correspondence: [email protected], [email protected] SUMMARY Neurofilaments (NFs) are unique among tissue-specific classes of intermediate filaments (IFs) in being heteropolymers composed of four subunits (NF-L [neurofilament light]; NF-M [neuro- filament middle]; NF-H [neurofilament heavy]; and a-internexin or peripherin), each having different domain structures and functions. Here, we review how NFs provide structural support for the highly asymmetric geometries of neurons and, especially, for the marked radial expan- sion of myelinated axons crucial for effective nerve conduction velocity. NFs in axons exten- sively cross-bridge and interconnect with other non-IF components of the cytoskeleton, including microtubules, actin filaments, and other fibrous cytoskeletal elements, to establish a regionallyspecialized networkthat undergoes exceptionallyslow local turnoverand serves as a docking platform to organize other organelles and proteins. We also discuss how a small pool of oligomeric and short filamentous precursors in the slow phase of axonal transport maintains this network. A complex pattern of phosphorylation and dephosphorylation events on each subunit modulates filament assembly, turnover, and organization within the axonal cytoskel- eton. Multiple factors, and especially turnover rate, determine the size of the network, which can vary substantially along the axon.
    [Show full text]
  • The Role of Tau in Amyloid Β Plaque Growth and Formation
    THE ROLE OF TAU IN AMYLOID β PLAQUE GROWTH AND FORMATION Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades an der Fakultät für Biologie der Ludwig-Maximilians-Universität München vorgelegt von Hazal Salihoglu München, den 07.06.2019 i Neyi arıyorsan O’sun sen. What you seek is seeking you. Was du suchst, sucht dich. Mevlana (1207-1273) i Diese Dissertation wurde unter der Leitung von Prof. Dr. Jochen Herms am Institut für Neuropathologie der Ludwig-Maximilians-Universität angefertigt und von Prof. Dr. Wolfgang Enard an der Fakultät für Biologie vertreten. Eidesstattliche Erklärung Ich versichere hiermit an Eides statt, dass die vorgelegte Dissertation von mir selbständig und ohne unerlaubte Hilfe angefertigt ist. Hiermit erkläre ich, dass die Dissertation nicht ganz oder in wesentlichen Teilen einer anderen Prüfungskommission vorgelegt worden ist und ich mich anderweitig einer Doktorprüfung ohne Erfolg nicht unterzogen habe. München, den 17.10.2018 Hazal Salihoglu Erstgutachter: Prof. Dr. Wolfgang Enard Zweitgutachter: Dr. rer. nat. Anja Horn-Bochtler Tag der Abgabe: 06.11.2018 Tag der mündlichen Prüfung: 27.05.19 ii Table of contents Table of Contents ACKNOWLEDGEMENTS .................................................................................................... 1 DECLARATION ................................................................................................................... 2 LIST OF FIGURES ..............................................................................................................
    [Show full text]
  • Cytoskeletal Proteins in Neurological Disorders
    cells Review Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders Diana C. Muñoz-Lasso 1 , Carlos Romá-Mateo 2,3,4, Federico V. Pallardó 2,3,4 and Pilar Gonzalez-Cabo 2,3,4,* 1 Department of Oncogenomics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; [email protected] 2 Department of Physiology, Faculty of Medicine and Dentistry. University of Valencia-INCLIVA, 46010 Valencia, Spain; [email protected] (C.R.-M.); [email protected] (F.V.P.) 3 CIBER de Enfermedades Raras (CIBERER), 46010 Valencia, Spain 4 Associated Unit for Rare Diseases INCLIVA-CIPF, 46010 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-963-395-036 Received: 10 December 2019; Accepted: 29 January 2020; Published: 4 February 2020 Abstract: Recent observations related to the structure of the cytoskeleton in neurons and novel cytoskeletal abnormalities involved in the pathophysiology of some neurological diseases are changing our view on the function of the cytoskeletal proteins in the nervous system. These efforts allow a better understanding of the molecular mechanisms underlying neurological diseases and allow us to see beyond our current knowledge for the development of new treatments. The neuronal cytoskeleton can be described as an organelle formed by the three-dimensional lattice of the three main families of filaments: actin filaments, microtubules, and neurofilaments. This organelle organizes well-defined structures within neurons (cell bodies and axons), which allow their proper development and function through life. Here, we will provide an overview of both the basic and novel concepts related to those cytoskeletal proteins, which are emerging as potential targets in the study of the pathophysiological mechanisms underlying neurological disorders.
    [Show full text]
  • Specialized Roles of Neurofilament Proteins in Synapses
    Brain Research Bulletin 126 (2016) 334–346 Contents lists available at ScienceDirect Brain Research Bulletin j ournal homepage: www.elsevier.com/locate/brainresbull Review Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders a,b,∗ a,b,c,∗ Aidong Yuan , Ralph A. Nixon a Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York, 10962, United States b Departments of Psychiatry, New York University School of Medicine, New York, NY, 10016, United States c Department of Cell Biology, New York University School of Medicine, New York, NY, 10016, United States a r t i c l e i n f o a b s t r a c t Article history: Neurofilaments are uniquely complex among classes of intermediate filaments in being composed of four Received 11 July 2016 subunits (NFL, NFM, NFH and alpha-internexin in the CNS) that differ in structure, regulation, and func- Received in revised form 2 September 2016 tion. Although neurofilaments have been traditionally viewed as axonal structural components, recent Accepted 3 September 2016 evidence has revealed that distinctive assemblies of neurofilament subunits are integral components Available online 5 September 2016 of synapses, especially at postsynaptic sites. Within the synaptic compartment, the individual subunits differentially modulate neurotransmission and behavior through interactions with specific neurotrans- Keywords: mitter receptors. These newly uncovered functions suggest that alterations of neurofilament proteins Neurofilament subunit Synapse not only underlie axonopathy in various neurological disorders but also may play vital roles in cog- nition and neuropsychiatric diseases. Here, we review evidence that synaptic neurofilament proteins Dendritic spine Neuropsychiatric disease are a sizable population in the CNS and we advance the concept that changes in the levels or post- translational modification of individual NF subunits contribute to synaptic and behavioral dysfunction in certain neuropsychiatric conditions.
    [Show full text]
  • Internexin Causes Abnormal Neurofilamentous Accumulations
    The Journal of Neuroscience, April 15, 1999, 19(8):2974–2986 Overexpression of a-Internexin Causes Abnormal Neurofilamentous Accumulations and Motor Coordination Deficits in Transgenic Mice Gee Y. Ching,1 Chung-Liang Chien,2 Roberto Flores,1 and Ronald K. H. Liem1 1Departments of Pathology and Anatomy and Cell Biology, Columbia University College of Physicians and Surgeons, New York, New York 10032, and 2Department of Anatomy, National Taiwan University School of Medicine, Taipei, Taiwan 100, Republic of China a-Internexin is the first neuronal intermediate filament (IF) pro- Behavioral tests demonstrate that these mice have a deficit in tein expressed in postmitotic neurons of the developing ner- motor coordination as early as 3 months of age, consistent with vous system. In the adult, its expression is restricted to mature the morphological neuronal changes. Our data further demon- neurons in the CNS. To study the potential role of a-internexin strate that the neurofilamentous inclusions also lead to progres- in neurodegeneration, we have generated transgenic mice that sive loss of neurons in the aged transgenic mice. The motor overexpress rat a-internexin. The total levels of a-internexin coordination deficit and the loss of neurons are transgene expressed in the hemizygous and homozygous transgenic mice dosage-dependent. These data yield direct evidence that high were ;2 and ;3 times the normal level, respectively. Overex- levels of misaccumulated neuronal IFs lead to neuronal dys- pression of a-internexin resulted in the formation of cerebellar function, progressive neurodegeneration, and ultimate loss of torpedoes as early as 1 month of age. These torpedoes are neurons.
    [Show full text]
  • Role of Gigaxonin in the Regulation of Intermediate Filaments: a Study Using Giant Axonal Neuropathy Patient-Derived Induced Pluripotent Stem Cell-Motor Neurons
    Role of Gigaxonin in the Regulation of Intermediate Filaments: a Study Using Giant Axonal Neuropathy Patient-Derived Induced Pluripotent Stem Cell-Motor Neurons Bethany Johnson-Kerner Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2013 © 2012 Bethany Johnson-Kerner All rights reserved Abstract Role of Gigaxonin in the Regulation of Intermediate Filaments: a Study Using Giant Axonal Neuropathy Patient-Derived Induced Pluripotent Stem Cell-Motor Neurons Bethany Johnson-Kerner Patients with giant axonal neuropathy (GAN) exhibit loss of motor and sensory function and typically live for less than 30 years. GAN is caused by autosomal recessive mutations leading to low levels of gigaxonin, a ubiquitously-expressed cytoplasmic protein whose cellular roles are poorly understood. GAN pathology is characterized by aggregates of intermediate filaments (IFs) in multiple tissues. Disorganization of the neuronal intermediate filament (nIF) network is a feature of several neurodegenerative disorders, including amyotrophic lateral sclerosis, Parkinson’s disease and axonal Charcot-Marie-Tooth disease. In GAN such changes are often striking: peripheral nerve biopsies show enlarged axons with accumulations of neurofilaments; so called “giant axons.” Interestingly, IFs also accumulate in other cell types in patients. These include desmin in muscle fibers, GFAP (glial fibrillary acidic protein) in astrocytes, and vimentin in multiple cell types including primary cultures of biopsied fibroblasts. These findings suggest that gigaxonin may be a master regulator of IFs, and understanding its function(s) could shed light on GAN as well as the numerous other diseases in which IFs accumulate.
    [Show full text]
  • Analysis of Protein Expression Regulated by Lumican in PANC‑1 Cells Using Shotgun Proteomics
    ONCOLOGY REPORTS 30: 1609-1621, 2013 Analysis of protein expression regulated by lumican in PANC‑1 cells using shotgun proteomics TETSUSHI YAMAMOTO, MITSUHIRO KUDO, WEI-XIA PENG and ZENYA NAITO Departments of Pathology and Integrative Oncological Pathology, Nippon Medical School, Bunkyo-ku, Tokyo 113-8602, Japan Received March 19, 2013; Accepted May 30, 2013 DOI: 10.3892/or.2013.2612 Abstract. Lumican, a member of the class II small leucine- the core protein (1,2). Amino acid sequencing indicates that rich proteoglycan family, regulates the assembly and diameter lumican has 4 potential sites for N-linked keratan sulfate (KS) of collagen fibers in the extracellular matrix of various tissues. or oligosaccharides (3,4). Therefore, lumican includes a core We previously reported that lumican expression in the stromal protein, glycoprotein and proteoglycan forms due to glycosyl- tissues of pancreatic ductal adenocarcinoma (PDAC) correlates ation (5). Lumican is a secreted collagen-binding extracellular with tumor invasion, and tends to correlate with poor prog- matrix protein of the cornea, dermis and tendon stroma, nosis. Lumican stimulates growth and inhibits the invasion of arterial wall, and intestinal submucosa (6-9). Corneal opacity, a PDAC cell line. In the present study, we performed a global as well as skin and tendon fragility due to disorganized and shotgun proteomic analysis using lumican-overexpressing loosely packed collagen fibers in lumican-null mice suggest PANC-1 cells and lumican downregulated PANC-1 cells to that lumican plays an important role in collagen fibrillogen- identify candidate proteins that are regulated by lumican and esis (10,11). related to cell growth and invasion in PDAC cells.
    [Show full text]